Cite
HARVARD Citation
Danaher, P. et al. (2018). Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA). Journal for immunotherapy of cancer. 6 (1), p. . [Online].